Expand ERAS Menu
ERAS MENU

ERAS Latest Press Releases

-- March 12, 2026 --

Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results Globe Newswire 4:01 PM

-- March 10, 2026 --

Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau Globe Newswire 8:00 AM

-- March 5, 2026 --

Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat Globe Newswire 7:01 AM

-- February 24, 2026 --

Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 Globe Newswire 8:00 AM

-- February 17, 2026 --

Registration Momentum Builds Across the Oncology Pipeline Globe Newswire 10:48 AM

-- February 5, 2026 --

Erasca to Present at Upcoming Conferences in February Globe Newswire 8:00 AM

-- January 23, 2026 --

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

-- January 21, 2026 --

Erasca Announces Pricing of Upsized Public Offering of Common Stock Globe Newswire 8:54 PM

-- January 20, 2026 --

Erasca Announces Proposed Public Offering of $150 Million of Common Stock Globe Newswire 4:01 PM

-- January 12, 2026 --

Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones Globe Newswire 8:00 AM

-- January 6, 2026 --

Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- November 25, 2025 --

Erasca to Present at the 8th Annual Evercore Healthcare Conference Globe Newswire 9:08 AM

-- November 19, 2025 --

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B Globe Newswire 9:45 AM
Market Data Delayed 15 Minutes